CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 113 entries

View as:

Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts

Phase: N/A Priority: Normal

NCT ID: NCT02536222 Org: User:

Start: 09/30/15 End: 07/31/16 Due: 07/31/17

Safety, Acceptability, and Feasibility of Enterade®

Phase: N/A Priority: Normal

NCT ID: NCT03782272 Org: User:

Start: 02/26/19 End: 06/30/20 Due: 06/30/21

Assessing a Risk Model for G6PD Deficiency

Phase: N/A Priority: Normal

NCT ID: NCT03337152 Org: User:

Start: 05/07/18 End: 10/21/18 Due: 10/21/19

A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine

Phase: N/A Priority: Normal

NCT ID: NCT01764256 Org: User:

Start: 12/31/12 End: 09/30/13 Due: 09/30/14

Comparing G6PD Tests Using Capillary Blood Versus Venous Blood

Phase: N/A Priority: Normal

NCT ID: NCT02069236 Org: User:

Start: 02/28/14 End: 12/31/14 Due: 12/31/15

Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults

Phase: N/A Priority: Normal

NCT ID: NCT02810340 Org: User:

Start: 08/01/16 End: 10/13/17 Due: 10/13/18

Honduras Liger Thermocoagulator Study

Phase: N/A Priority: Normal

NCT ID: NCT03510273 Org: User:

Start: 05/04/18 End: 10/29/19 Due: 10/29/20

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

Phase: N/A Priority: Normal

NCT ID: NCT00463476 Org: User:

Start: 07/09/07 End: 10/02/08 Due: 10/02/09

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

Phase: N/A Priority: Normal

NCT ID: NCT04344054 Org: User:

Start: 02/22/21 End: 09/09/22 Due: 09/09/23

Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Phase: N/A Priority: Normal

NCT ID: NCT02286895 Org: User:

Start: 10/31/14 End: 03/31/15 Due: 03/31/16

Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso

Phase: N/A Priority: Normal

NCT ID: NCT04545905 Org: User:

Start: 09/22/20 End: 07/31/22 Due: 07/31/23

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

Phase: N/A Priority: Normal

NCT ID: NCT05527990 Org: User:

Start: 03/20/22 End: 12/31/23 Due: 12/31/24

Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe

Phase: N/A Priority: Normal

NCT ID: NCT01742364 Org: User:

Start: 12/31/12 End: 12/31/13 Due: 12/31/14

Cholera Anti-Secretory Treatment Trial

Phase: N/A Priority: Normal

NCT ID: NCT04150250 Org: User:

Start: 11/04/19 End: 07/27/20 Due: 07/27/21

Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants

Phase: N/A Priority: Normal

NCT ID: NCT02109484 Org: User:

Start: 03/31/14 End: 11/30/15 Due: 11/30/16

Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test

Phase: N/A Priority: Normal

NCT ID: NCT01530672 Org: User:

Start: 01/31/12 End: 09/30/13 Due: 09/30/14

Stimulating Private Sector Malaria Control

Phase: N/A Priority: Normal

NCT ID: NCT01397851 Org: User:

Start: 12/31/10 End: 12/31/13 Due: 12/31/14

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

Phase: N/A Priority: Normal

NCT ID: NCT01328457 Org: User:

Start: 01/31/11 End: 06/30/12 Due: 06/30/13

Performance and Safety Evaluation of an Intradermal Delivery Device

Phase: N/A Priority: Normal

NCT ID: NCT01359111 Org: User:

Start: 05/31/11 End: 05/31/11 Due: 05/31/12

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Phase: N/A Priority: Normal

NCT ID: NCT00216346 Org: User:

Start: 06/30/03 End: 11/30/04 Due: 11/30/05

Safety and Immunogenicity Study of Trivalent P2-VP8 Subunit Rotavirus Vaccine in Adults, Toddlers and Infants

Phase: N/A Priority: Normal

NCT ID: NCT02646891 Org: User:

Start: 02/15/16 End: 12/22/17 Due: 12/22/18

Study to Determine Impact of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa

Phase: N/A Priority: Normal

NCT ID: NCT02162498 Org: User:

Start: 08/31/13 End: 08/31/15 Due: 08/31/16

Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia

Phase: N/A Priority: Normal

NCT ID: NCT02329301 Org: User:

Start: 09/30/14 End: 08/31/20 Due: 08/31/21

Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia

Phase: N/A Priority: Normal

NCT ID: NCT05621876 Org: User:

Start: 05/15/24 End: 09/30/24 Due: 09/30/25

Proactive Community Case Management for Malaria in Zambia

Phase: N/A Priority: Normal

NCT ID: NCT04839900 Org: User:

Start: 04/15/21 End: 12/30/23 Due: 12/30/24

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts	NCT02536222	PATH	user2@example.com	None	2015-09-30	2016-07-31	2017-07-31	-	-	2025-07-14
Safety, Acceptability, and Feasibility of Enterade®	NCT03782272	PATH	user2@example.com	None	2019-02-26	2020-06-30	2021-06-30	-	-	2025-07-14
Assessing a Risk Model for G6PD Deficiency	NCT03337152	PATH	user2@example.com	None	2018-05-07	2018-10-21	2019-10-21	-	-	2025-07-14
A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine	NCT01764256	PATH	user2@example.com	None	2012-12-31	2013-09-30	2014-09-30	-	-	2025-07-14
Comparing G6PD Tests Using Capillary Blood Versus Venous Blood	NCT02069236	PATH	user2@example.com	None	2014-02-28	2014-12-31	2015-12-31	-	-	2025-07-14
Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults	NCT02810340	PATH	user2@example.com	None	2016-08-01	2017-10-13	2018-10-13	-	-	2025-07-14
Honduras Liger Thermocoagulator Study	NCT03510273	PATH	user2@example.com	None	2018-05-04	2019-10-29	2020-10-29	-	-	2025-07-14
Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine	NCT00463476	PATH	user2@example.com	None	2007-07-09	2008-10-02	2009-10-02	-	-	2025-07-14
Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine	NCT04344054	PATH	user2@example.com	None	2021-02-22	2022-09-09	2023-09-09	-	-	2025-07-14
Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali	NCT02286895	PATH	user2@example.com	None	2014-10-31	2015-03-31	2016-03-31	-	-	2025-07-14
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso	NCT04545905	PATH	user2@example.com	None	2020-09-22	2022-07-31	2023-07-31	-	-	2025-07-14
TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters	NCT05527990	PATH	user2@example.com	None	2022-03-20	2023-12-31	2024-12-31	-	-	2025-07-14
Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe	NCT01742364	PATH	user2@example.com	None	2012-12-31	2013-12-31	2014-12-31	-	-	2025-07-14
Cholera Anti-Secretory Treatment Trial	NCT04150250	PATH	user2@example.com	None	2019-11-04	2020-07-27	2021-07-27	-	-	2025-07-14
Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants	NCT02109484	PATH	user2@example.com	None	2014-03-31	2015-11-30	2016-11-30	-	-	2025-07-14
Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test	NCT01530672	PATH	user2@example.com	None	2012-01-31	2013-09-30	2014-09-30	-	-	2025-07-14
Stimulating Private Sector Malaria Control	NCT01397851	PATH	user2@example.com	None	2010-12-31	2013-12-31	2014-12-31	-	-	2025-07-14
An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh	NCT01328457	PATH	user2@example.com	None	2011-01-31	2012-06-30	2013-06-30	-	-	2025-07-14
Performance and Safety Evaluation of an Intradermal Delivery Device	NCT01359111	PATH	user2@example.com	None	2011-05-31	2011-05-31	2012-05-31	-	-	2025-07-14
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis	NCT00216346	PATH	user2@example.com	None	2003-06-30	2004-11-30	2005-11-30	-	-	2025-07-14
Safety and Immunogenicity Study of Trivalent P2-VP8 Subunit Rotavirus Vaccine in Adults, Toddlers and Infants	NCT02646891	PATH	user2@example.com	None	2016-02-15	2017-12-22	2018-12-22	-	-	2025-07-14
Study to Determine Impact of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa	NCT02162498	PATH	user2@example.com	None	2013-08-31	2015-08-31	2016-08-31	-	-	2025-07-14
Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia	NCT02329301	PATH	user2@example.com	None	2014-09-30	2020-08-31	2021-08-31	-	-	2025-07-14
Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia	NCT05621876	PATH	user2@example.com	None	2024-05-15	2024-09-30	2025-09-30	-	-	2025-07-14
Proactive Community Case Management for Malaria in Zambia	NCT04839900	PATH	user2@example.com	None	2021-04-15	2023-12-30	2024-12-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance